133 related articles for article (PubMed ID: 25201490)
1. Adding the acetylcholinesterase inhibitor, donepezil, to losartan treatment markedly improves long-term survival in rats with chronic heart failure.
Li M; Zheng C; Kawada T; Inagaki M; Uemura K; Sugimachi M
Eur J Heart Fail; 2014 Oct; 16(10):1056-65. PubMed ID: 25201490
[TBL] [Abstract][Full Text] [Related]
2. Donepezil markedly improves long-term survival in rats with chronic heart failure after extensive myocardial infarction.
Li M; Zheng C; Kawada T; Inagaki M; Uemura K; Shishido T; Sugimachi M
Circ J; 2013; 77(10):2519-25. PubMed ID: 23832513
[TBL] [Abstract][Full Text] [Related]
3. Donepezil attenuates progression of cardiovascular remodeling and improves prognosis in spontaneously hypertensive rats with chronic myocardial infarction.
Li M; Zheng C; Kawada T; Uemura K; Yokota S; Matsushita H; Saku K
Hypertens Res; 2024 May; 47(5):1298-1308. PubMed ID: 38485776
[TBL] [Abstract][Full Text] [Related]
4. Anti-Alzheimer's drug, donepezil, markedly improves long-term survival after chronic heart failure in mice.
Handa T; Katare RG; Kakinuma Y; Arikawa M; Ando M; Sasaguri S; Yamasaki F; Sato T
J Card Fail; 2009 Nov; 15(9):805-11. PubMed ID: 19879468
[TBL] [Abstract][Full Text] [Related]
5. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
Tao ZW; Huang YW; Xia Q; Xu QW
Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801
[TBL] [Abstract][Full Text] [Related]
6. Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction.
Guo X; Wang J; Elimban V; Dhalla NS
Can J Physiol Pharmacol; 2008 Apr; 86(4):139-47. PubMed ID: 18418421
[TBL] [Abstract][Full Text] [Related]
7. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats.
Li M; Zheng C; Sato T; Kawada T; Sugimachi M; Sunagawa K
Circulation; 2004 Jan; 109(1):120-4. PubMed ID: 14662714
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of low-dose combination therapy with a statin and an angiotensin receptor blocker in a rat myocardial infarction model.
Sohma R; Inoue T; Abe S; Taguchi I; Kikuchi M; Toyoda S; Arikawa T; Hikichi Y; Sanada S; Asanuma H; Kitakaze M; Node K
J Cardiol; 2012 Jan; 59(1):91-6. PubMed ID: 21925839
[TBL] [Abstract][Full Text] [Related]
9. Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction.
Connelly KA; Advani A; Advani S; Zhang Y; Thai K; Thomas S; Krum H; Kelly DJ; Gilbert RE
Cardiovasc Ther; 2013 Apr; 31(2):84-91. PubMed ID: 21884026
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
11. Specific Inhibition of Brain Angiotensin III Formation as a New Strategy for Prevention of Heart Failure After Myocardial Infarction.
Leenen FHH; Ahmad M; Marc Y; Llorens-Cortes C
J Cardiovasc Pharmacol; 2019 Feb; 73(2):82-91. PubMed ID: 30531435
[TBL] [Abstract][Full Text] [Related]
12. Effect of the cholinesterase inhibitor donepezil on cardiac remodeling and autonomic balance in rats with heart failure.
Okazaki Y; Zheng C; Li M; Sugimachi M
J Physiol Sci; 2010 Jan; 60(1):67-74. PubMed ID: 19949913
[TBL] [Abstract][Full Text] [Related]
13. Impact of Peripheral α7-Nicotinic Acetylcholine Receptors on Cardioprotective Effects of Donepezil in Chronic Heart Failure Rats.
Li M; Zheng C; Kawada T; Inagaki M; Uemura K; Akiyama T; Sugimachi M
Cardiovasc Drugs Ther; 2021 Oct; 35(5):877-888. PubMed ID: 32860618
[TBL] [Abstract][Full Text] [Related]
14. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
[TBL] [Abstract][Full Text] [Related]
15. Effects of combined inhibition of the Na+-H+ exchanger and angiotensin-converting enzyme in rats with congestive heart failure after myocardial infarction.
Ruetten H; Gehring D; Hiss K; Schindler U; Gerl M; Busch AE; Schaefer S
Br J Pharmacol; 2005 Nov; 146(5):723-31. PubMed ID: 16151439
[TBL] [Abstract][Full Text] [Related]
16. Depression of efferent parasympathetic control of heart rate in rats with myocardial infarction: effect of losartan.
Du XJ; Cox HS; Dart AM; Esler MD
J Cardiovasc Pharmacol; 1998 Jun; 31(6):937-44. PubMed ID: 9641480
[TBL] [Abstract][Full Text] [Related]
17. Donepezil, a potential therapeutic agent for heart failure.
Chen A; Chen YM
Eur J Heart Fail; 2015 Feb; 17(2):233. PubMed ID: 25678099
[No Abstract] [Full Text] [Related]
18. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
Xu R; Zhang Y; Zhang M; Li XC; Cai H; Chen WQ; Zhu H; Ge ZM; Zhang W
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3199-204. PubMed ID: 16405840
[TBL] [Abstract][Full Text] [Related]
19. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats.
Xu X; Wan W; Ji L; Lao S; Powers AS; Zhao W; Erikson JM; Zhang JQ
Cardiovasc Res; 2008 Jun; 78(3):523-32. PubMed ID: 18252761
[TBL] [Abstract][Full Text] [Related]
20. Sympathetic hyperactivity and cardiac dysfunction post-MI: different impact of specific CNS versus general AT1 receptor blockade.
Huang BS; Ahmad M; Tan J; Leenen FH
J Mol Cell Cardiol; 2007 Oct; 43(4):479-86. PubMed ID: 17714732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
